Literature DB >> 29018085

Evaluating the effects of Quebec's private-public drug insurance system.

Steven G Morgan1, Marc-André Gagnon2, Mathieu Charbonneau2, Alain Vadeboncoeur2.   

Abstract

Mesh：

Year:  2017        PMID： 29018085      PMCID： PMC5636629          DOI： 10.1503/cmaj.170726

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  11 in total

1.  Impact of a cost sharing drug insurance plan on drug utilization among individuals receiving social assistance.

Authors:  Lucie Blais; Julie Couture; Elham Rahme; Jacques LeLorier
Journal:  Health Policy       Date:  2003-05       Impact factor: 2.980

2.  Mandatory universal drug plan, access to health care and health: Evidence from Canada.

Authors:  Chao Wang; Qing Li; Arthur Sweetman; Jeremiah Hurley
Journal:  J Health Econ       Date:  2015-08-19       Impact factor: 3.883

3.  Public/private partnerships for prescription drug coverage: policy formulation and outcomes in Quebec's universal drug insurance program, with comparisons to the Medicare prescription drug program in the United States.

Authors:  Marie-Pascale Pomey; Pierre-Gerlier Forest; Howard A Palley; Elisabeth Martin
Journal:  Milbank Q       Date:  2007-09       Impact factor: 4.911

4.  Canadian pharmacare: looking back, looking forward.

Authors:  Steven G Morgan; Jamie R Daw
Journal:  Healthc Policy       Date:  2012-08

5.  Quebec employs user-pay philosophy in launching drug-insurance plan.

Authors:  M Martin
Journal:  CMAJ       Date:  1996-12-01       Impact factor: 8.262

6.  Estimated cost of universal public coverage of prescription drugs in Canada.

Authors:  Steven G Morgan; Michael Law; Jamie R Daw; Liza Abraham; Danielle Martin
Journal:  CMAJ       Date:  2015-03-16       Impact factor: 8.262

7.  Cost-related nonadherence to prescribed medicines among older Canadians in 2014: a cross-sectional analysis of a telephone survey.

Authors:  Augustine Lee; Steve Morgan
Journal:  CMAJ Open       Date:  2017-01-17

8.  Drivers of expenditure on primary care prescription drugs in 10 high-income countries with universal health coverage.

Authors:  Steven G Morgan; Christine Leopold; Anita K Wagner
Journal:  CMAJ       Date:  2017-06-12       Impact factor: 8.262

9.  Adverse events associated with prescription drug cost-sharing among poor and elderly persons.

Authors:  R Tamblyn; R Laprise; J A Hanley; M Abrahamowicz; S Scott; N Mayo; J Hurley; R Grad; E Latimer; R Perreault; P McLeod; A Huang; P Larochelle; L Mallet
Journal:  JAMA       Date:  2001 Jan 24-31       Impact factor: 56.272

10.  Cost-related non-adherence to prescribed medicines among older adults: a cross-sectional analysis of a survey in 11 developed countries.

Authors:  Steven G Morgan; Augustine Lee
Journal:  BMJ Open       Date:  2017-01-31       Impact factor: 2.692
View more
  8 in total

1.  How to pay for national pharmacare.

Authors:  Michael C Wolfson; Steven G Morgan
Journal:  CMAJ       Date:  2018-11-26       Impact factor: 8.262

2.  Election 2019: unprecedented hope for universal pharmacare.

Authors:  Matthew B Stanbrook
Journal:  CMAJ       Date:  2019-10-15       Impact factor: 8.262

Review 3.  A systematic umbrella review of the association of prescription drug insurance and cost-sharing with drug use, health services use, and health.

Authors:  G Emmanuel Guindon; Tooba Fatima; Sophiya Garasia; Kimia Khoee
Journal:  BMC Health Serv Res       Date:  2022-03-03       Impact factor: 2.655

4.  Inequity in insurance coverage for prescription drugs in New Brunswick, Canada.

Authors:  Busola Ayodele; Elaine Xiaoyu Guo; Arthur Sweetman; G Emmanuel Guindon
Journal:  Can J Public Health       Date:  2022-04-29

5.  It's Time to Finally Kill the Zombies Comment on "Universal Pharmacare in Canada".

Authors:  Joel Lexchin
Journal:  Int J Health Policy Manag       Date:  2020-12-01

6.  Emergency contraception subsidy in Canada: a comparative policy analysis.

Authors:  Sabrina C Lee; Wendy V Norman
Journal:  BMC Health Serv Res       Date:  2022-09-01       Impact factor: 2.908

Review 7.  Prescription drug coverage in Canada: a review of the economic, policy and political considerations for universal pharmacare.

Authors:  Jaden Brandt; Brenna Shearer; Steven G Morgan
Journal:  J Pharm Policy Pract       Date:  2018-11-07

Review 8.  Not All Canadian Cancer Patients Are Equal-Disparities in Public Cancer Drug Funding across Canada.

Authors:  Ceilidh MacPhail; Stephanie Snow
Journal:  Curr Oncol       Date:  2022-03-17       Impact factor: 3.677
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.